Michael Reardon
This video is part of CTSNet’s 2025 Resident Video Competition. Watch all entries into the competition, including the winning videos. The patient was a 21-year-old female with a past medical history of attention-deficit hyperactivity disorder...
In May 2024, The Diagnostic and Therapeutic Center of Athens Hygeia organized the Transcatheter Heart Valves Greece 2024. The conference featured pivotal specialty insights from both local faculty and internationally...
In this recording from the 2023 Transcatheter Heart Valves Greece conference, Dr. Michael J. Reardon, a cardiothoracic surgeon at Methodist DeBaket Heart and Vascular Center, discusses varying confidence in the...
CTSNet had the great privilege of hosting an expert-filled roundtable on aortic root enlargement (AAE) vs. total root replacement (ARR) for the small aortic root. Barbara Hamilton moderated the debate...
CTSNet is excited to host a debate on the topic of aortic root enlargement (AAE) vs. total root replacement (ARR) for the small aortic root. Cardiac surgery experts Bo Yang,...
This is the case of a transcatheter aortic valve replacement (TAVR) explantation due to late thrombosis leading to cardiogenic shock. The patient was a sixty-seven-year-old woman with a complex medical...
The patient is a sixty-seven-year-old female who underwent aortic valve replacement in 2018 with a 19 mm bioprosthetic aortic valve. In this case, the patient presented to the medical center...
This video offers a step-by-step approach to transcatheter aortic valve replacement (TAVR) using a self-expanding valve. It features the case of a patient at intermediate surgical risk who chose to...
Filmed at the 2020 STS Annual Meeting in New Orleans, Louisiana, Tsuyoshi Kaneko of Brigham and Women’s Hospital in Boston, Massachusetts, USA, moderates a discussion on surgical and transcatheter management...
Educational Grants CTSNet wishes to recognize and thank the following companies for their ongoing support through educational grants: Edwards Lifesciences. In March 2019, two randomized trials were published comparing surgical...
Transcatheter aortic valve replacement (TAVR) is changing the landscape of the treatment of structural heart disease. There are now more TAVRs than isolated surgical AVRs done in the USA. The...
Complete surgical resection is the optimal treatment for malignant and complex benign left heart tumors. Anatomic inaccessibility and the relationship with vital cardiac structures can make complete resection of these...
Papillary fibroelastoma is the most common benign tumor of the cardiac valvular apparatus, and is considered the second most common type of cardiac tumor. Advancement in trans-esophageal echocardiography technology has...








